SJ Berwin retains its positions on the IP rankings this year. The firm provides expertise across the spectrum of law, and enjoys a considerable reputation for its litigation practice, where it is particularly known for representing generic pharmaceutical companies. The IP team welcomes the addition of a new partner in London this year in the form of a promotion from senior associate for Chris Thornham in May 2010. The firm advised NGN Capital in May 2010 regarding a financing round for biotechnology company Noxxon Pharma in Germany. The IP team in Berlin assisted in related patent advice and commercial work.